UNICREDIT BANK/PUT/AMGEN/200/0.1/15.01.25 | Real-time BOERSE MUENCHEN 05:10:26 26/06/2024 pm IST | ||
| 0.065 EUR | -32.99% |
|
| Current month | -55.91% | ||
| 1 month | -55.91% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 0.065 | -32.99% |
| 25/24/25 | 0.097 | -11.82% |
| 24/24/24 | 0.11 | -15.38% |
| 21/24/21 | 0.13 | -7.14% |
| 20/24/20 | 0.14 | +218.18% |
Real-time BOERSE MUENCHEN
Last update June 26, 2024 at 05:10 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC3JAS |
| ISIN | DE000HC3JAS5 |
| Date issued | 26/01/2023 |
| Strike | 200 $ |
| Maturity | 15/01/2025 (203 Days) |
| Parity | 10 : 1 |
| Emission price | 1.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.8 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Warrants
- Warrant
